The Cleveland Clinic is part of a multisite trial studying psilocybin to help patients with treatment-resistant depression.

Dr. Brian Barnett shows the inside of the dosing room at Cleveland Clinic Lutheran where participants in a study looking at ...

Psilocybin has been studied as a possible treatment for post-traumatic stress disorder (PTSD), depression and substance use ...

Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.

Psilocybin use in the U.S. has risen sharply across all age groups since 2019, coinciding with increasing legalization and interest in its therapeutic potential.

Denver, Colorado became the first U.S. city to decriminalize psilocybin - a chemical found in "magic mushrooms" - in May of ...

A new study reveals that chronic stress activates immune cells that travel to the brain, amplify inflammation, and heighten ...

The Iowa House voted 84-6 to advance a proposal to legalize psilocybin for psychiatric treatment through a program similar to ...

Such a dynamic was in evidence with U.K.-based Compass Pathways (NASDAQ: CMPS) this week. On news about a step completed in a ...

Compass Pathways (CMPS) announced that all participants have completed dosing in Part A of the COMP005 phase 3 trial for treatment resistant ...

COMP360 is a synthesized, proprietary formulation of psilocybin under investigation as a treatment for certain difficult-to-treat mental health conditions. Depression is one of the most common ...

The Department of Veterans ­Affairs will fund MDMA and ­psilocybin-assisted therapies for veterans with post-traumatic stress ...